Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value: $85.2M (100.0% shares, 0.0% debt)

Holdings (19)

MLTX MOONLAKE IMMUNOTHERAPEUTICS 12.3%

Value $10.44M Shares 183,105 Est. Cost $37.06 Unrealized +49.0%

XENE XENON PHARMACEUTICALS INC 10.7%

Value $9.119M Shares 266,961 Est. Cost $36.94 Unrealized +1.2%

— INTRA-CELLULAR THERAPIES INC 10.7%

Value $9.116M Shares 175,000 Est. Cost $52.09 Unrealized —

AXSM AXSOME THERAPEUTICS INC 9.1%

Value $7.73M Shares 110,600 Est. Cost $74.75 Unrealized 0.0%

APLS APELLIS PHARMACEUTICALS INC 8.1%

Value $6.916M Shares 181,805 Est. Cost $43.93 Unrealized 0.0%

CYTK CYTOKINETICS INC 7.7%

Value $6.581M Shares 223,382 Est. Cost $40.80 Unrealized -18.4%

— MERUS NV 6.1%

Value $5.22M Shares 221,384 Est. Cost $18.92 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 5.9%

Value $4.993M Shares 272,690 Est. Cost $21.15 Unrealized 0.0%

GERN GERON CORP 5.5%

Value $4.71M Shares 2,221,639 Est. Cost $2.84 Unrealized -4.4%

ARDX ARDELYX INC 4.2%

Value $3.596M Shares 881,356 Est. Cost $3.90 Unrealized 0.0%

— AMBRX BIOPHARMA INC 3.8%

Value $3.233M Shares 281,089 Est. Cost $11.50 Unrealized —

— MIRATI THERAPEUTICS INC 3.6%

Value $3.062M Shares 70,283 Est. Cost $43.56 Unrealized —

— JASPER THERAPEUTICS INC 2.6%

Value $2.201M Shares 3,144,164 Est. Cost $1.59 Unrealized —

BDTX BLACK DIAMOND THERAPEUTICS I 2.1%

Value $1.82M Shares 634,191 Est. Cost $2.04 Unrealized +80.4%

— PRAXIS PRECISION MEDICINES I 2.1%

Value $1.806M Shares 1,056,370 Est. Cost $1.15 Unrealized —

CMPX COMPASS THERAPEUTICS INC 2.1%

Value $1.802M Shares 914,630 Est. Cost $3.14 Unrealized -21.2%

CNTX CONTEXT THERAPEUTICS INC 1.3%

Value $1.096M Shares 725,951 Est. Cost $0.88 Unrealized +28.6%

— PROMIS NEUROSCIENCES INC 1.2%

Value $1.053M Shares 531,915 Est. Cost $1.98 Unrealized —

MDVLQ MEDAVAIL HOLDINGS INC 0.8%

Value $707K Shares 117,897 Est. Cost $10.12 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	183,105	$10.44M	12.3%	$37.06	+49.0%	CLASS A ORD	61559X104
XENE	XENON PHARMACEUTICALS INC	266,961	$9.119M	10.7%	$36.94	+1.2%	COM	98420N105
—	INTRA-CELLULAR THERAPIES INC	175,000	$9.116M	10.7%	$52.09	—	COM	46116X101
AXSM	AXSOME THERAPEUTICS INC	110,600	$7.73M	9.1%	$74.75	0.0%	COM	05464T104
APLS	APELLIS PHARMACEUTICALS INC	181,805	$6.916M	8.1%	$43.93	0.0%	COM	03753U106
CYTK	CYTOKINETICS INC	223,382	$6.581M	7.7%	$40.80	-18.4%	COM NEW	23282W605
—	MERUS NV	221,384	$5.22M	6.1%	$18.92	—	COM	N5749R100
AMLX	AMYLYX PHARMACEUTICALS INC	272,690	$4.993M	5.9%	$21.15	0.0%	COM	03237H101
GERN	GERON CORP	2,221,639	$4.71M	5.5%	$2.84	-4.4%	COM	374163103
ARDX	ARDELYX INC	881,356	$3.596M	4.2%	$3.90	0.0%	COM	039697107
—	AMBRX BIOPHARMA INC	281,089	$3.233M	3.8%	$11.50	—	SPONSORED ADS	02290A102
—	MIRATI THERAPEUTICS INC	70,283	$3.062M	3.6%	$43.56	—	COM	60468T105
—	JASPER THERAPEUTICS INC	3,144,164	$2.201M	2.6%	$1.59	—	COM	471871103
BDTX	BLACK DIAMOND THERAPEUTICS I	634,191	$1.82M	2.1%	$2.04	+80.4%	COM	09203E105
—	PRAXIS PRECISION MEDICINES I	1,056,370	$1.806M	2.1%	$1.15	—	COM	74006W108
CMPX	COMPASS THERAPEUTICS INC	914,630	$1.802M	2.1%	$3.14	-21.2%	COM	20454B104
CNTX	CONTEXT THERAPEUTICS INC	725,951	$1.096M	1.3%	$0.88	+28.6%	COM	21077P108
—	PROMIS NEUROSCIENCES INC	531,915	$1.053M	1.2%	$1.98	—	COM NEW	74346M406
MDVLQ	MEDAVAIL HOLDINGS INC	117,897	$707K	0.8%	$10.12	0.0%	COM NEW	58406B202